Abstract:ADPRHL2 is involved in posttranslational modification and is known to have a role in physiological functions such as cell signaling, DNA repair, gene control, cell death, and response to stress. Recently, a group of neurological disorders due to ADPRHL2 variants is described, characterized by childhood-onset, stress-induced variable movement disorders, neuropathy, seizures, and neurodegenerative course. We present the diagnostic pathway of two pediatric patients with episodic dystonia and ataxia, who later had a neurodegenerative course complicated by central hypoventilation syndrome due to the same homozygous ADPRHL2 variant. We conducted a systematic literature search and data extraction procedure following the Preferred Reporting Items for Systematic Review and Meta-Analysis 2020 statement in terms of patients with ADPRHL2 variants, from 2018 up to 3 February, 2023. In total, 12 articles describing 47 patients were included in the final analysis. Median age at symptom onset was 2 (0.7–25) years, with the most common presenting symptoms being gait problems ( n = 19, 40.4%), seizures ( n = 16, 34%), ataxia ( n = 13, 27.6%), and weakness ( n = 10, 21.2%). Triggering factors (28/47; 59.5%) and regression (28/43; 60.4%), axonal polyneuropathy (9/23; 39.1%), and cerebral and cerebellar atrophy with white matter changes (28/36; 77.7%) were the other clues. The fatality rate and median age of death were 44.6% ( n = 21) and 7 (2–34) years, respectively. ADPRHL2 variants should be considered in the context of episodic, stress-induced pediatric and adult-onset movement disorders and seizures. 1. Research project: A. Conception, B. Organization, and C. Execution. 2. Statistical analysis: A. Design, B. Execution, and C. Review and critique. 3. Manuscript preparation: A. Writing of the first draft and B. Review and Critique. S.Ö.Y.: 1A, 2A, 2B, 3A; D.Y.: 3B; P.Ö.Ş.K.: 1A, 3B; R.G.: 3B; M.S.: 3B; G.E.U.: 3B; and G.H.: 1A, 1B, 1C, 2C, 3B. The authors confirm that the approval of an institutional review board was not required for this work. Written and verbal consent from the parents were obtained for this study, including case presentations and video images. We confirm that we have read the journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. None. Informed consent was obtained. Received: 27 September 2023 Accepted: 29 December 2023 Article published online: 16 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

A novel variant in disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure

Novel heterozygous variant of ADPRHL2 causes pathogenic variation in CONDSIAS

Delineation of ADPRHL2 Variants: Report of Two New Patients with Review of the Literature

Epileptic encephalopathy linked to a DALRD3 missense variant impaired in tRNA modification function

Capillary gas chromatographic method for mandelic and phenylglyoxylic acids in urine

The Aggravation of Neuropsychiatric Symptoms in the Offspring of a Korean Family with Intellectual Disability and Developmental Delay Caused by a Novel ARX p.Lys385Ter Variant

A milder form of NSRP1‐associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal

variants leading to epigenetic machinery dysfunction are associated with a neurodevelopmental disorder

A non-coding variant in the Kozak sequence of RARS2 strongly decreases protein levels and causes pontocerebellar hypoplasia

Study of Novel NARS2 Variants in Patient of Combined Oxidative Phosphorylation Deficiency 24

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

Early-onset dysphagia and severe neurodevelopmental disorder as early signs in a patient with two novel variants in NARS1: a case report and brief review of the literature

Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder

Neurodevelopmental disorders associated variants in ADAT3 disrupt the activity of the ADAT2/ADAT3 tRNA deaminase complex and impair neuronal migration.

Characterization of a New Variant in ARHGAP31 Probably Involved in Adams–Oliver Syndrome in a Family with a Variable Phenotypic Spectrum

Bi-allelic SNAPC4 variants dysregulate global alternative splicing and lead to neuroregression and progressive spastic paraparesis

Ascorbate peroxidase and catalase cooperate for protection against hydrogen peroxide generated in potato tubers during low‐temperature storage

Detection of Partial Denaturation in AT-Rich DNA Fragments by Ion-Pair Reversed-Phase Chromatography.

Biallelic NDC1 variants that interfere with ALADIN binding are associated with neuropathy and triple A-like syndrome

A novel variant in ASNS gene responsible for syndromic intellectual disability and microcephaly: Case report and literature review

A Novel ARL3 Gene Mutation Associated With Autosomal Dominant Retinal Degeneration